日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarate

乳腺腺癌中异柠檬酸脱氢酶1 (IDH1) 突变与血清和尿液中2-羟基戊二酸水平升高相关。

Fathi, Amir T; Sadrzadeh, Hossein; Comander, Amy H; Higgins, Michaela J; Bardia, Aditya; Perry, Ashley; Burke, Meghan; Silver, Regina; Matulis, Christina R; Straley, Kimberly S; Yen, Katharine E; Agresta, Sam; Kim, Hyeryun; Schenkein, David P; Borger, Darrell R

Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping

通过广泛的肿瘤基因分型发现胆管癌中异柠檬酸脱氢酶(IDH)1和IDH2频繁突变

Borger, Darrell R; Tanabe, Kenneth K; Fan, Kenneth C; Lopez, Hector U; Fantin, Valeria R; Straley, Kimberly S; Schenkein, David P; Hezel, Aram F; Ancukiewicz, Marek; Liebman, Hannah M; Kwak, Eunice L; Clark, Jeffrey W; Ryan, David P; Deshpande, Vikram; Dias-Santagata, Dora; Ellisen, Leif W; Zhu, Andrew X; Iafrate, A John

Cancer-associated isocitrate dehydrogenase mutations

癌症相关的异柠檬酸脱氢酶突变

Yen, Katharine E; Schenkein, David P

Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy

利用磁共振波谱法对IDH1突变型胶质瘤患者体内2-羟基戊二酸及其他代谢物进行无创检测

Pope, Whitney B; Prins, Robert M; Albert Thomas, M; Nagarajan, Rajakumar; Yen, Katharine E; Bittinger, Mark A; Salamon, Noriko; Chou, Arthur P; Yong, William H; Soto, Horacio; Wilson, Neil; Driggers, Edward; Jang, Hyun G; Su, Shinsan M; Schenkein, David P; Lai, Albert; Cloughesy, Timothy F; Kornblum, Harley I; Wu, Hong; Fantin, Valeria R; Liau, Linda M

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

癌症相关代谢物2-羟基戊二酸在伴有异柠檬酸脱氢酶1和2突变的急性髓系白血病中积累

Gross, Stefan; Cairns, Rob A; Minden, Mark D; Driggers, Edward M; Bittinger, Mark A; Jang, Hyun Gyung; Sasaki, Masato; Jin, Shengfang; Schenkein, David P; Su, Shinsan M; Dang, Lenny; Fantin, Valeria R; Mak, Tak W

Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma.

复发难治性多发性骨髓瘤患者接受硼替佐米治疗后血小板减少症的风险因素和动力学

Lonial Sagar, Waller Edmund K, Richardson Paul G, Jagannath Sundar, Orlowski Robert Z, Giver Cynthia R, Jaye David L, Francis Dixil, Giusti Sara, Torre Claire, Barlogie Bart, Berenson James R, Singhal Seema, Schenkein David P, Esseltine Dixie-Lee W, Anderson Jessica, Xiao Hugh, Heffner Leonard T, Anderson Kenneth C